ANVISA implemented a new subject code specifically for bioequivalence-related petitions. This update enhances submission traceability, improves workflow classification, and supports more efficient regulatory review processes for bioequivalence studies within the Brazilian regulatory system.
Select Mandate HA
Select Mandate Function